Multifunctional synthetic nano-chaperone for peptide folding and intracellular delivery
- Authors
- Park I.-S.; 김성찬; Yim Yeajee; Park Ginam; Choi Jinahn; Won Cheolhee; Min Dal-Hee
- Issue Date
- 2022-08
- Publisher
- Nature Publishing Group
- Citation
- Nature Communications, v.13, no.1
- Abstract
- Artificial, synthetic chaperones have attracted much attention in biomedical research due to their ability to control the folding of proteins and peptides. Here, we report bio-inspired multifunctional porous nanoparticles to modulate proper folding and intracellular delivery of therapeutic α-helical peptide. The Synthetic Nano-Chaperone for Peptide (SNCP) based on porous nanoparticles provides an internal hydrophobic environment which contributes in stabilizing secondary structure of encapsulated α-helical peptides due to the hydrophobic internal environments. In addition, SNCP with optimized inner surface modification not only improves thermal stability for α-helical peptide but also supports the peptide stapling methods in situ, serving as a nanoreactor. Then, SNCP subsequently delivers the stabilized therapeutic α-helical peptides into cancer cells, resulting in high therapeutic efficacy. SNCP improves cellular uptake and bioavailability of the anti-cancer peptide, so the cancer growth is effectively inhibited in vivo. These data indicate that the bio-inspired SNCP system combining nanoreactor and delivery carrier could provide a strategy to expedite the development of peptide therapeutics by overcoming existing drawbacks of α-helical peptides as drug candidates.
- Keywords
- MESOPOROUS SILICA NANOPARTICLES; PROTEIN SECONDARY STRUCTURE; ARTIFICIAL CHAPERONES; MOLECULAR CHAPERONES; P53; ACTIVATION; APOPTOSIS; TARGET
- ISSN
- 2041-1723
- URI
- https://pubs.kist.re.kr/handle/201004/76633
- DOI
- 10.1038/s41467-022-32268-2
- Appears in Collections:
- KIST Article > 2022
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.